World News: 12:30 GMT Thursday 8th February 2018. [Innovation Pharmaceuticals, Inc. via Globe Newswire via SPi World News]
BEVERLY Mass Feb 08 2018 GLOBE NEWSWIRE -- Innovation Pharmaceuticals Inc (OTCQB:IPIX) the Company a clinical stage biopharmaceutical company, today announces the closure of its Phase 2a clinical trial of Kevetrin for the trea tment o...
Globe Newswire: 12:30 GMT Thursday 8th February 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.